Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

INTRODUCTION: Identifying ankylosing spondylitis (AS) patients who are likely to benefit from tumor necrosis factor-alpha (TNF-α) blocking therapy is important, especially in view of the costs and potential side effects of these agents. Recently, the AS Disease Activity Score (ASDAS) has been develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, Suzanne, Brouwer, Elisabeth, van der Veer, Eveline, Groen, Henk, Leijsma, Martha K, Houtman, Pieternella M, Th A Jansen, Tim L, Kallenberg, Cees GM, Spoorenberg, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218909/
https://www.ncbi.nlm.nih.gov/pubmed/21689401
http://dx.doi.org/10.1186/ar3369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218909/
https://www.ncbi.nlm.nih.gov/pubmed/21689401
http://dx.doi.org/10.1186/ar3369

Ejemplares similares